Camena Bioscience appoints Gregory P. McGuinness as CEO
2 minute read
Download press release Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discovery, and operational scaling